Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2012, Article ID 904946, 6 pages
http://dx.doi.org/10.1155/2012/904946
Clinical Study

Transcription Expression and Clinical Significance of Dishevelled-3 mRNA and -Catenin mRNA in Pleural Effusions from Patients with Lung Cancer

1Department of Pathology, The First Affiliated Hospital and College of Basic Medical Sciences, China Medical University, Shenyang 110001, China
2Center of Biochip, College of Basic Medical Sciences, China Medical University, Shenyang 110001, China

Received 20 October 2011; Revised 12 December 2011; Accepted 19 December 2011

Academic Editor: Hans Wilhelm Nijman

Copyright © 2012 Xiao-Yan Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Marel, B. Stastny, L. Melinova, E. Svandova, and R. W. Light, “Diagnosis of pleural effusions: experience with clinical studies, 1986 to 1990,” Chest, vol. 107, no. 6, pp. 1598–1603, 1995. View at Google Scholar · View at Scopus
  2. K. N. Fenton and J. D. Richardson, “Diagnosis and management of malignant pleural effusions,” American Journal of Surgery, vol. 170, no. 1, pp. 69–74, 1995. View at Publisher · View at Google Scholar · View at Scopus
  3. S. M. A. Ghayumi, S. Mehrabi, M. Doroudchi, and A. Ghaderi, “Diagnostic value of tumor markers for differentiating malignant and benign pleural effusions of Iranian patients,” Pathology and Oncology Research, vol. 11, no. 4, pp. 236–241, 2005. View at Google Scholar · View at Scopus
  4. A. M. Afify, R. Stern, and C. W. Michael, “Differentiation of mesothelioma from adenocarcinoma in serous effusions: the role of hyaluronic acid and CD44 localization,” Diagnostic Cytopathology, vol. 32, no. 3, pp. 145–150, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. G. P. Wu, S. S. Zhang, C. Q. Fang, S. L. Liu, and E. H. Wang, “Immunocytochemical panel for distinguishing carcinoma cells from reactive mesothelial cells in pleural effusions,” Cytopathology, vol. 19, no. 4, pp. 212–217, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. W. B. Zhou, M. Bai, and Y. Jin, “Diagnostic value of vascular endothelial growth factor and endostatin in malignant pleural effusions,” International Journal of Tuberculosis and Lung Disease, vol. 13, no. 3, pp. 381–386, 2009. View at Google Scholar · View at Scopus
  7. A. M. Afify, B. M. Al-Khafaji, A. F. G. Paulino, and R. M. Davila, “Diagnostic use of muscle markers in the cytologic evaluation of serous fluids,” Applied Immunohistochemistry and Molecular Morphology, vol. 10, no. 2, pp. 178–182, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Queiroz, M. Barral-Netto, and C. E. Bacchi, “Characterizing subpopulations of neoplastic cells in serous effusions: the role of immunocytochemistry,” Acta Cytologica, vol. 45, no. 1, pp. 18–22, 2001. View at Google Scholar · View at Scopus
  9. B. Jiang, G. P. Wu, Y. J. Zhao, and S. C. Wang, “Transcription expression and clinical significance of TTF-1 mRNA in pleural effusion of patients with lung cancer,” Diagnostic Cytopathology, vol. 36, no. 12, pp. 849–854, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Sun, G. P. Wu, C. Q. Fang, and S. L. Liu, “Diagnostic utility of MOC-31, HBME-1 and MOC-31mRNA in distinguishing between carcinoma cells and reactive mesothelial cells in pleural effusions,” Acta Cytologica, vol. 53, no. 6, pp. 619–624, 2009. View at Google Scholar · View at Scopus
  11. Q. Wei, Y. Zhao, Z. Q. Yang et al., “Dishevelled family proteins are expressed in non-small cell lung cancer and function differentially on tumor progression,” Lung Cancer, vol. 62, no. 2, pp. 181–192, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. I. Israely, R. M. Costa, C. W. Xie, A. J. Silva, K. S. Kosik, and X. Liu, “Deletion of the neuron-specific protein delta-catenin leads to severe cognitive and synaptic dysfunction,” Current Biology, vol. 14, no. 18, pp. 1657–1663, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Y. Zhang, Y. Wang, D. Zhang et al., “δ-catenin promotes malignant phenotype of non-small cell lung cancer by non-competitive binding to E-cadherin with p120ctn in cytoplasm,” Journal of Pathology, vol. 222, no. 1, pp. 76–88, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. S. D. Dai, Y. Wang, J. Y. Zhang et al., “Upregulation of δ-catenin is associated with poor prognosis and enhances transcriptional activity through Kaiso in non-small-cell lung cancer,” Cancer Science, vol. 102, no. 1, pp. 95–103, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Politi, C. Kandaraki, C. Apostolopoulou, T. Kyritsi, and H. Koutselini, “Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids,” Diagnostic Cytopathology, vol. 32, no. 3, pp. 151–155, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. N. G. Ordóñez, “The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma,” American Journal of Surgical Pathology, vol. 27, no. 8, pp. 1031–1051, 2003. View at Publisher · View at Google Scholar
  17. H. Yaziji, H. Battifora, T. S. Barry et al., “Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity,” Modern Pathology, vol. 19, no. 4, pp. 514–523, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. T. D. Bui, D. R. Beier, M. Jonssen et al., “cDNA cloning of a human dishevelled DVL-3 gene, mapping to 3q27, and expression in human breast and colon carcinomas,” Biochemical and Biophysical Research Communications, vol. 239, no. 2, pp. 510–516, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Overhauser, X. Huang, M. Gersh et al., “Molecular and phenotypic mapping of the short arm of chromosome 5: sublocalization of the critical region for the cri-du-chat syndrome,” Human Molecular Genetics, vol. 3, no. 2, pp. 247–252, 1994. View at Google Scholar · View at Scopus
  20. K. S. Kosik, C. P. Donahue, I. Israely, X. Liu, and T. Ochiishi, “δ-Catenin at the synaptic-adherens junction,” Trends in Cell Biology, vol. 15, no. 3, pp. 172–178, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Kurusu, J. I. Yamashita, and M. Ogawa, “Detection of circulating tumor cells by reverse transcriptase-polymerase chain reaction in patients with resectable non-small-cell lung cancer,” Surgery, vol. 126, no. 5, pp. 820–826, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Von Knebel Doeberitz and J. Lacroix, “Nucleic acid based techniques for the detection of rare cancer cells in clinical samples,” Cancer and Metastasis Reviews, vol. 18, no. 1, pp. 43–64, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Saintigny, S. Coulon, M. Kambouchner et al., “Real-time RT-PCR detection of CK19, CK7 and MUC1 mRNA for diagnosis of lymph node micrometastases in non small cell lung carcinoma,” International Journal of Cancer, vol. 115, no. 5, pp. 777–782, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. Q. Dong, J. Huang, Y. Zhou et al., “Hematogenous dissemination of lung cancer cells during surgery: quantitative detection by flow cytometry and prognostic significance,” Lung Cancer, vol. 37, no. 3, pp. 293–301, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Hermanek, R. V. P. Hutter, L. H. Sobin, and C. Wittekind, “Classification of isolated tumor cells and micrometastasis,” Cancer, vol. 86, no. 12, pp. 2668–2673, 1999. View at Google Scholar · View at Scopus